These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9740217)

  • 1. Antibody to tumor necrosis factor in the treatment of Crohn's disease.
    Stricker T; Braegger CP
    J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):369-70. PubMed ID: 9740217
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.
    Bell S; Kamm MA
    Lancet; 2000 Mar; 355(9207):858-60. PubMed ID: 10752696
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibody approved for treatment of Crohn's disease.
    Freeman TR; Piascik P
    J Am Pharm Assoc (Wash); 1998; 38(6):770-2. PubMed ID: 9861797
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies targeting tumor necrosis factor in Crohn's disease.
    Sandborn WJ
    Acta Gastroenterol Belg; 2001; 64(2):170-2. PubMed ID: 11475128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab treatment for Crohn's disease.
    Conroy CA; Cattell R
    Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
    [No Abstract]   [Full Text] [Related]  

  • 7. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.
    D'haens G; Van Deventer S; Van Hogezand R; Chalmers D; Kothe C; Baert F; Braakman T; Schaible T; Geboes K; Rutgeerts P
    Gastroenterology; 1999 May; 116(5):1029-34. PubMed ID: 10220494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TNF antibody treatment of Crohn's disease.
    van Deventer SJ
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I114-20. PubMed ID: 10577987
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of fistulas in Crohn's disease with infliximab.
    Löfberg R
    Gut; 1999 Nov; 45(5):642-3. PubMed ID: 10517896
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.
    Baert FJ; D'Haens GR; Peeters M; Hiele MI; Schaible TF; Shealy D; Geboes K; Rutgeerts PJ
    Gastroenterology; 1999 Jan; 116(1):22-8. PubMed ID: 9869598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus nephritis improvement after anti-tumor necrosis factor alpha monoclonal antibody (infliximab) treatment for Crohn's disease: a case report.
    Principi M; Di Leo A; Ingrosso M; Pisani A; Marangi S; Amoruso A; Panella C; Francavilla A; Ierardi E
    Immunopharmacol Immunotoxicol; 2004 May; 26(2):243-8. PubMed ID: 15209360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Crohn's disease with anti-TNF alpha].
    Lémann M
    Rev Prat; 1998 May; 48(10):1049-50. PubMed ID: 9781146
    [No Abstract]   [Full Text] [Related]  

  • 13. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
    Hawkey CJ; Stack WA
    N Engl J Med; 1998 Jan; 338(5):333-4. PubMed ID: 9446034
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab: how to use it in pediatric Crohn's disease.
    Ruemmele FM
    J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):12-4. PubMed ID: 15187774
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).
    van Dullemen HM; van Deventer SJ; Hommes DW; Bijl HA; Jansen J; Tytgat GN; Woody J
    Gastroenterology; 1995 Jul; 109(1):129-35. PubMed ID: 7797011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab therapy in Crohn's disease: safety issues.
    Hommes DW; van Deventer SJ
    Neth J Med; 2003 Apr; 61(4):100-4. PubMed ID: 12852717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of psychosis with infliximab in a patient with Crohn's disease.
    Reimer J; Fink T; Bläker M; Schäfer I; Otte C
    Schizophr Res; 2009 Apr; 109(1-3):194-5. PubMed ID: 19223267
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions.
    Oh CJ; Das KM; Gottlieb AB
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):829-30. PubMed ID: 10775863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab (Remicade) for Crohn's disease.
    Med Lett Drugs Ther; 1999 Feb; 41(1047):19-20. PubMed ID: 10076592
    [No Abstract]   [Full Text] [Related]  

  • 20. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
    Bauditz J; Lochs H; Schreiber S
    N Engl J Med; 1998 Jan; 338(5):334. PubMed ID: 9446035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.